Effect of risedronate on joint structure and symptoms of knee osteoarthritis: results of the BRISK randomized, controlled trial [ISRCTN01928173]

To determine the efficacy and safety of risedronate in patients with knee osteoarthritis (OA), the British study of risedronate in structure and symptoms of knee OA (BRISK), a 1-year prospective, double-blind, placebo-controlled study, enrolled patients (40–80 years of age) with mild to moderate OA...

Descripción completa

Detalles Bibliográficos
Autores principales: Spector, Tim D, Conaghan, Philip G, Buckland-Wright, J Christopher, Garnero, Patrick, Cline, Gary A, Beary, John F, Valent, David J, Meyer, Joan M
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1174954/
https://www.ncbi.nlm.nih.gov/pubmed/15899049
http://dx.doi.org/10.1186/ar1716

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1174954/
https://www.ncbi.nlm.nih.gov/pubmed/15899049
http://dx.doi.org/10.1186/ar1716

Ejemplares similares